Stability-indicating HPLC method for simultaneous determination of clidinium bromide and chlordiazepoxide in combined dosage forms

Journal of Chromatographic Science

Volumn 48, Issue 3, 2010, Pages 235-239

  Pathak, Ashutosh ^a   Rai, Pallavi ^a   Rajput, Sadhana J ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949307444     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/48.3.235     Document Type: Article

References (17)

1. M.I. Toral, P. Richter, N. Lara, P. Jaque, C. Soto, and M. Saavedra. Simultaneous determinationof chlordiazepoxideandclidiniumbromideinpharmaceutical formulations by derivative spectrophotometry. Int. J. Pharm. 189: 67-74 (1999).
2. J. Gasparic and J. Zimak. Analysis of the 1,4-benzodiazepines by methods based on hydrolysis. J. Pharm. Biomed. Anal. 1: 259-279 (1983).
3. G.K. Mcevory (Ed) AHFS Drug Information, American Society of Hospital Pharmacists. pp. 1256-1258 (1990).
4. B. Nickerson. The determination of a degradation product in clidinium bromide drug substance by capillary electrophoresis with indirect UV detection. J. Pharm. Biomed. Anal. 15: 965-971 (1997).
5. Y.M. Issa, N.T. Abdel-Ghani, A.F. Shoukry, and H.M. Ahmed. New conventional coated-wire ion-selective electrodes for flow-injection potentiometric determination of chlordiazepoxide. Anal. Sci. 21: 1037-1042 (2005).
6. G.B El-Hefnawey, I.S. El-Hallag, E.M. Ghoneim, and M.M. Ghoneim. Voltammetric behavior and quantification of the sedative-hypnotic drug chlordiazepoxide in bulk form, pharmaceutical formulation and human serum at a mercury electrode. J. Pharm. Biomed. Anal. 34: 75-86 (2004)
7. D. Song, S. Zhang, and K. Kohlhof. Determination of chlordiazepoxide in mouse plasma by gas chromatography-negative-ionchemical ionizationmass spectrometry. J. Chromatogr. 660: 95-101 (1994).
8. M. Mazzei, A. Balbi, G. Roma, M. Di Braccio, and L. Robbiano. HPLC analysis of the nitrosation products of chlordiazepoxide. Farmaco 44: 883-889 (1989).
9. A.G. Davidson. Assay of chlordiazepoxide and demoxepam in chlordiazepoxide formulations by difference spectrophotometry. J. Pharm. Sci. 73: 55-58 (1984)
10. M. Divoll, D.J. Greenblatt, and R.I. Shader. Liquid chromatographic determination of chlordiazepoxide and metabolites in plasma. Pharmacol. 24: 261-266 (1982).
11. S. Stahlmann and K.A. Kovar. Analysis of impurities by high-performance thin-layer chromatography with Fourier transform infrared spectroscopy and UV absorbancedetectioninsitumeasurement: chlordiazepoxideinbulkpowderand in tablets. J. Chromatogr. A 813: 145-152 (1998).
12. S.M. Yuen and G. Lehr. Liquid chromatographic determination of clidinium bromide and clidinium bromide-chlordiazepoxide hydrochloride combinations in capsules. J. Assoc. Off. Anal. Chem. 74: 461-464 (1991)
13. ICH, Q1A Stability testing of new drug substances and products, in: Proceedings of the international conference on harmonization, Geneva, Switzerland, October, 1993.
14. ICH, Q2B, Harmonised tripartite guideline, Validation of analytical procedure: Methodology, International conference on harmonization, Geneva, Switzerland, March 1996.
15. ICH Guidance on analytical method validation, International convention on quality for the pharmaceutical industry, Toronto, Canada, September 2002.
16. ICH, Q1B, Stability testing: photostability testing of new drug substances and products. In: International Conference on Harmonization, IFPMA, Geneva, Switzerland, 1996.
17. The United States Pharmacopeia, USP-24, NF-19, United States Pharmacopoeial Convention, INC, Rockville, MD, Asian Edition, 2000, pp. 2149-2151.